rheumatologyadvisor7h
Romvimza Approved for Symptomatic Tenosynovial Giant Cell Tumor
The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...
Medscape1d
This Radiation Therapy Outperformed TACE in Liver Cancer
New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in ...
Daily7h
Faecal Elastase-1 Test May Help Diagnose Pancreatic Exocrine Insufficiency After Pancreatic Resection: Study
In the research published in BMC Surgery, fecal elastase-1 (FE-1) test emerged as the most frequently utilized diagnostic ...
Too Old to Operate12d
In Lung Cancer, Novel Preoperative Biomarkers Predict Recurrence Risk
Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...
Healio8d
FDA approves Gomekli for neurofibromatosis type 1 with plexiform neurofibromas
The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
Benign Prostatic Hyperplasia Surgical Treatment Market to Hit USD 17.19 Billion by 2030 with 5.3% CAGR | MarketsandMarkets™
The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...